Population immunology: Building immune barriers to confront the global challenges of respiratory pathogens
-
-
REFERENCES
[1] Li J., Huan Y., Xia Q., et al. (2025). H3N2 influenza virus characteristics in China (2019–2022): Genetic, antigenic, and infection dynamics during the COVID-19 pandemic. hLife 3:146-158. DOI:10.1016/j.hlife.2025.01.004 [2] Guo Y., Gu K., Garber P.A., et al. (2024). A comparative analysis of influenza and COVID-19: Environmental-ecological impacts, socioeconomic implications, and future challenges. Biosaf. Health 6:369-375. DOI:10.1016/j.bsheal.2024.10.001 [3] Menezes R.C., Ferreira I.B.B., Sobral L., et al. (2023). Severe viral lower respiratory tract infections in Brazilian children: Clinical features of a national cohort. J. Infect. Public Health 17:1−9. DOI:10.1016/j.jiph.2023.09.015 [4] Koutsakos M., Wheatley A.K., Laurie K., et al. (2021). Influenza lineage extinction during the COVID-19 pandemic. Nat. Rev. Microbiol. 19:741−742. DOI:10.1038/s41579-021-00642-4 [5] Ran Z., Shen H., Lang Y., et al. (2015). Domestic pigs are susceptible to infection with influenza B viruses. J. Virol. 89:4818−4826. DOI:10.1128/JVI.00059-15 [6] Rowntree L.C., Allen L.F., Hagen R.R., et al. (2025). HLA-B*15:01-positive severe COVID-19 patients lack CD8+ T cell pools with highly expanded public clonotypes. Proc. Natl. Acad. Sci. U. S. A. 122:e2503145122. DOI:10.1073/pnas.2503145122 [7] Wang X., Zhang J., Liu M., et al. (2024). Nonconserved epitopes dominate reverse preexisting T cell immunity in COVID-19 convalescents. Signal. Transduct. Target. Ther. 9:160. DOI:10.1038/s41392-024-01876-3 [8] Liu W.J. and Liu S. (2021). A tale of two cities: From influenza HxNy to SARS-CoV-z. China CDC Wkly. 3:1052−1056. DOI:10.46234/ccdcw2021.256 [9] Lin Y., He X., Lei W., et al. (2023). Cold-chain-based epidemiology: scientific evidence and logic in introduction and transmission of SARS-CoV-2. Glob. Transit. 5:170-181. DOI:10.1016/j.glt.2023.09.003 [10] Cao C., Zhao W., Guo J., et al. (2025). Leveraging artificial intelligence and machine learning for unraveling pathogenesis and advancing precision medicine in autoimmune diseases. Innov. Med. 3:100154. DOI:10.59717/j.xinn-med.2025.100154 -
ABOUT THIS ARTICLE
Cite this article:
Liu J. (2026). Population immunology: Building immune barriers to confront the global challenges of respiratory pathogens. The Innovation Medicine 4:100220. https://doi.org/10.59717/j.xinn-med.2026.100220
Welcome!
To request copyright permission to republish or share portions of our works, please visit Copyright Clearance Center's (CCC) Marketplace website at marketplace.copyright.com.
Export File
Citation
Liu J. (2026). Population immunology: Building immune barriers to confront the global challenges of respiratory pathogens. The Innovation Medicine 4:100220. https://doi.org/10.59717/j.xinn-med.2026.100220
Format
Content
DownLoad:
-
Figure 1.
Herein, I propose three possible patterns of interaction between population immune barrier (PIB) and the epidemic of respiratory infectious diseases
